retatrutide data Results: 28.3% Weight Loss Retatrutide Dose Escalation Chart &

4 Myth : All GLP-1 weight-loss drugs are the same

modest heart rate increases were also observed

Medicare GLP-1 Bridge program Beginning July 1, 2026 through December 31, 2027, eligible Medicare beneficiaries can access the following FDA-approved GLP-1 medications for weight loss : Wegovy (injection or tablet), Foundayo (tablet), and Zepbound (KwikPen only) for $50/month *** through the Medicare GLP-1 Bridge program

Oral dosing of recombinant methioninase is associated with a 70% Drop in PSA in a patient with bone-metastatic prostate cancer and 50% Reduction in circulating methionine in a high-stage ovarian cancer patient

J.GubasA.ToozeS